Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-445
Closed -$201K 209
2020
Q2
$201K Buy
+445
New +$199K 0.03% 191
2019
Q3
Sell
-667
Closed -$241K 193
2019
Q2
$241K Hold
667
0.04% 171
2019
Q1
$213K Buy
+667
New +$205K 0.04% 171
2018
Q4
Sell
-667
Closed -$213K 175
2018
Q3
$213K Sell
667
-333
-33% -$106K 0.04% 169
2018
Q2
$322K Hold
1,000
0.07% 139
2018
Q1
$273K Hold
1,000
0.06% 149
2017
Q4
$243K Hold
1,000
0.05% 159
2017
Q3
$202K Hold
1,000
0.05% 169
2017
Q2
$205K Buy
+1,000
New +$199K 0.05% 169

Other funds holding CHE

Fiduciary Group's CHE Position: Q3 2020 in Review

Fiduciary Group sold out of Chemed (CHE) in Q3 2020, closing a stake of 445 shares — an estimated $201K sold.

Fiduciary Group first reported a position in CHE in Q2 2017 and held it in 9 quarters. The position peaked at $322K in Q2 2018. 446 funds tracked by Wall St. Rank hold CHE as of Q3 2020.

  • Fiduciary Group reported no remaining Chemed position as of Q3 2020 after selling out during the quarter.
  • Fiduciary Group sold 445 Chemed shares in Q3 2020, an estimated $201K.
  • Fiduciary Group first reported a position in Chemed in Q2 2017 and held it in 9 quarters.
  • Fiduciary Group's Chemed position peaked at $322K in Q2 2018.
  • 446 funds tracked by Wall St. Rank held Chemed as of Q3 2020.

Based on Fiduciary Group's 13F filing for Q3 2020, filed 12 Nov 2020.